Lepermislibre SA
PAR:ALLPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lepermislibre SA
PAR:ALLPL
|
FR |
|
A
|
American International Group Inc
XETRA:AINN
|
US |
|
Lanxess AG
OTC:LNXSF
|
DE |
|
Unicharm Corp
F:UN4
|
JP |
|
U
|
Under Armour Inc
XETRA:U9RA
|
US |
|
I
|
Isracann Biosciences Inc
OTC:ISCNF
|
CA |
|
Heidelberger Beteiligungsholding AG
F:IPOK
|
DE |
|
I
|
Innocan Pharma Corp
XBER:IP4
|
IL |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
Z
|
Zalando SE
LSE:0QXN
|
DE |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
G
|
Golar LNG Ltd
LSE:0HDY
|
BM |
|
Besqab AB (publ)
LSE:0QUY
|
SE |
|
V
|
Vinci SA
SWB:SQU
|
FR |
|
GlobalData PLC
LSE:DATA
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALLPL's stock price target?
Not Available
ALLPL does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Lepermislibre SA?
Projected CAGR
5%
Over the last 3 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 2 years is 5%.